Shengnuo Biotechnology (688117.SH) released its semi-annual performance results, with a net profit attributable to shareholders of 88.96 million yuan, an increase of 308.29% year-on-year.

Smart Finance APP News, Shengnuo Biology (688117.SH) disclosed its 2025 interim report. During the reporting period, the company achieved a revenue of 338 million yuan, a year-on-year increase of 69.69%; the net profit attributable to shareholders of the listed company was 88.96 million yuan, a year-on-year increase of 308.29%; the non-net profit was 89.48 million yuan, a year-on-year increase of 367.92%; basic earnings per share was 0.57 yuan.